Considering that DN is characterized by renal inflammatory fibrosis and PAQR3 regulates insulin resistance, glycolipid metabolism, and inflammatory response, we are highly concerned whether PAQR3 can regulate diabetic renal inflammatory fibrosis, eventually contributing to DN. Here, PAQR3 is linked to Insulin resistance.